Clinical Trial Update: Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating FOL-005 for safety and hair growth has completed, with results relevant to hypertrichosis, alopecia, and hirsutism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia
• Hirsutism
• Hypertrichosis

Drugs mentioned

• FOL-005

Snippet

Sponsor: Follicum AB | Conditions: Hypertrichosis, Alopecia | Phase 1, Phase 2 | Status: COMPLETED